Stock & Company Details
4D Molecular Therapeutics Inc $FDMT
Price:
N/A
N/A
55M
$714M
52 Week High:
N/A
10 Day Average Volume:
N/A
-4.74
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
FDMT technical indicators
Latest 4D Molecular Therapeutics Inc (FDMT) indicator readings as of 2026-10-29.
FDMT's 14-day RSI is 49.9, in neutral territory. At $12.78 it is trading 17.7% above its 200-day moving average of $10.86, and below its 50-day average of $13.80. Price sits in the middle of its Bollinger Bands ($11.12 to $13.85). ADX reads 14.7, indicating a range-bound market rather than a trend.
Overview
4D Molecular Therapeutics Inc a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built portfolio of gene therapy product candidates focused in three therapeutic areas: ophthalmology (intravitreal vector), cardiology (intravenous vector) and pulmonology (aerosol vector). It has three product candidates in clinical trials: 4D-125 for the treatment of X-linked retinitis pigmentosa in a Phase 1/2 clinical trial, 4D-110 for the treatment of choroideremia in a Phase 1 clinical trial, and 4D-310 for the treatment of Fabry disease in a Phase 1/2 clinical trial. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration, and 4D-710 for the treatment of cystic fibrosis lung disease.
Finance Bot
Ask your questions
Start by typing a question below.
